Realcan Pharmaceutical Group Co., Ltd. (002589.SZ)

CNY 3.25

(0.31%)

Market Cap (In CNY)

4.15 Billion

Revenue (In CNY)

8.03 Billion

Net Income (In CNY)

20.31 Million

Avg. Volume

19.37 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.05-3.67
PE
-
EPS
-
Beta Value
0.541
ISIN
CNE1000013X5
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Distribution
CEO
Mr. Xu Han
Employee Count
-
Website
https://www.realcan.cn
Ipo Date
2011-06-10
Details
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. It sells drugs, vaccines, and medical devices. The company also provides medical logistics services; third-party logistics services; disinfection and sterilization; and lease, and hospital logistics services for medical institutions. It serves drug distribution, academic services, medical diagnosis, financial technology, traditional Chinese medicine, digital medical care, professional logistics, and comprehensive equipment. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.